Cypris Medical, Inc. — Form D/A

Cypris Medical, Inc. of CHICAGO, IL, a company, filed a Form D amendment with the SEC on 2018-09-26. The offering totals $850K, of which $592K was reported sold. Industry: Biotechnology.

Offering

Filed: 2018-09-26
Form: D/A
Accession: 0001667655-18-000003
Industry: Biotechnology
Exemptions: 06b
Total offering: $850K
Amount sold: $592K
Remaining: $258K
Minimum investment: $1
Investors: 18
Date of first sale: 2018-02-23
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-306301

Issuer

Name: Cypris Medical, Inc.
CIK: 0001667655
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2016
Address: 4541 N RAVENSWOOD, CHICAGO, IL, 60640
Phone: (847) 563-0025

Officers, directors & promoters (6)

Name	Role	Location
LOUIS BUCKY	Director	IRVINE, CA
Grant Stevens	Director	Reno, NV
Daniel Holton	Director	Chicago, IL
Daniel Holton	Executive Officer	Chicago, IL
Roger Holton	Director	Chicago, IL
Christopher Godek	Director	Chicago, IL

Other filings by this issuer (9)

Filed	Form	Offering	Sold
2020-06-30	D	$150K	$150K
2019-02-25	D/A	$1.1M	$817K
2019-01-22	D/A	$1.1M	$798K
2018-02-23	D	$750K	$230K
2017-09-07	D/A	—	$755K
2017-06-05	D/A	$500K	$297K
2016-08-25	D/A	$500K	$75K
2016-08-25	D/A	$500K	$75K
2016-03-08	D	$500K	$75K

More